Insmed (INSM) Amortizatization of Intangibles (2013 - 2026)
Insmed's (INSM) quarterly Amortizatization of Intangibles came in at $678000.0 in Q1 2026, little changed year-on-year from $678000.0 in Q1 2025, and little changed quarter-over-quarter from $678000.0 in Q4 2025.
Insmed (INSM) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Insmed's Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $678000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $678000.0 in Q1 2026; TTM through Mar 2026 was $2.7 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.7 million, changed 0.0% from the prior year.
- Amortizatization of Intangibles was little changed at $678000.0 in Q1 2026 per INSM's latest filing, from $678000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $729000.0 in Q1 2022 and bottomed at $114000.0 in Q4 2022.
- The 5-year median for Amortizatization of Intangibles is $678000.0 (2023), against an average of $633764.7.
- Across the five-year window, Amortizatization of Intangibles slumped 99.6% in 2022 and jumped 494.74% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $114000.0 in 2022, then soared by 494.74% to $678000.0 in 2023, then changed by 0.0% to $678000.0 in 2024, then changed by 0.0% to $678000.0 in 2025, then changed by 0.0% to $678000.0 in 2026.
- Per Business Quant, the three latest INSM Amortizatization of Intangibles figures stand at $678000.0 (Q1 2026), $678000.0 (Q4 2025), and $678000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Insmed | 22.60 Bn | 21.38 Bn | 258.54 Mn | 678,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 678,000.00 |
| Mar 31, 2026 | 678,000.00 |
| Dec 31, 2025 | 678,000.00 |
| Dec 31, 2025 | 678,000.00 |
| Sep 30, 2025 | 678,000.00 |
| Sep 30, 2025 | 678,000.00 |
| Jun 30, 2025 | 678,000.00 |
| Jun 30, 2025 | 678,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 678,000.00 |
| Dec 31, 2024 | 678,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Dec 31, 2023 | 678,000.00 |
| Dec 31, 2023 | 678,000.00 |